business
Crescent Capital BDC Q1 Earnings Call Highlights
Key takeaways
- Crescent Capital BDC Q1 Earnings Call Highlights Market Beat Fri, May 15, 2026 at 12:09 AM GMT+7 7 min read CCAP FCRX Key Points Interested in Crescent Capital BDC, Inc.?
- Q1 earnings weakened as net investment income fell to $0.38 per share from $0.45, while NAV dropped to $18.27 from $19.10.
- Crescent raised its non-accruals to 5.7% of debt investments at cost, with five new problem loans concentrated in healthcare.
Crescent Capital BDC Q1 Earnings Call Highlights Market Beat Fri, May 15, 2026 at 12:09 AM GMT+7 7 min read CCAP FCRX Key Points Interested in Crescent Capital BDC, Inc.? Here are five stocks we like better.
Q1 earnings weakened as net investment income fell to $0.38 per share from $0.45, while NAV dropped to $18.27 from $19.10. Management said higher non-accruals, lower base rates, and credit-market volatility were the main pressures.
Crescent raised its non-accruals to 5.7% of debt investments at cost, with five new problem loans concentrated in healthcare. Management said the issues are specific to a small number of portfolio companies rather than broad-based stress in the sector.
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Also covered by
Investing.com
Earnings call transcript: Extendicare Inc. Q1 2026 earnings beat estimates
Investing.com
Earnings call transcript: Cellebrite Q1 2026 earnings beat estimates
Investing.com
Earnings call transcript: Definity Financial exceeds Q1 2026 expectations
Investing.com
Earnings call transcript: WhiteFiber Q1 2026 sees significant EPS miss
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop